Latest Articles
Hidden crisis in gynaecological cancers affecting women - The Courier | Ballarat, VIC
Hidden crisis in gynaecological cancers affecting women The Courier | Ballarat, VIC
Published: April 14, 2025, 5:24 a.m.
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" - BioSpace
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" BioSpace
Published: April 8, 2025, 8:04 p.m.
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" - Yahoo
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" Yahoo
Published: April 8, 2025, 2:12 p.m.
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" - Business Wire
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" Business Wire
Published: April 8, 2025, 2:12 p.m.
Revolutionary AI spots nearly 100% of cancers, beating doctors - AOL.com
Revolutionary AI spots nearly 100% of cancers, beating doctors AOL.com
Published: April 4, 2025, 12:53 p.m.
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature
Published: April 1, 2025, 1:15 p.m.
Revolutionary AI spots nearly 100% of cancers, beating doctors - AOL
Revolutionary AI spots nearly 100% of cancers, beating doctors AOL
Published: March 30, 2025, 6:33 p.m.
Revolutionary AI spots nearly 100% of cancers, beating doctors - The Brighter Side of News
Revolutionary AI spots nearly 100% of cancers, beating doctors The Brighter Side of News
Published: March 29, 2025, 4:07 p.m.
Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial - Fierce Biotech
Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial Fierce Biotech
Published: March 26, 2025, 11:05 a.m.
Endometriosis: assessment on O-RADS and risk of malignant transformation.
Endometriosis is a common disease, affecting approximately 10% of women of reproductive age. Several intersecting guidelines and consensus statements provide information on imaging diagnosis and surveillance strategies for endometriomas. SRU …
Published: March 26, 2025, midnight
Link copied to clipboard!